Endoglin (CD105) is an auxiliary membrane receptor of transforming growth factor beta
(TGF‐β) that interacts with type I and type II TGF‐β receptors and modulates TGF‐β …

Endoglin (CD105) is an accessory receptor for transforming growth factor beta (TGF-β) and
its expression is up-regulated in actively proliferating endothelial cells. Endoglin has been …

Endoglin (CD105) is an auxiliary receptor for members of the TFG-β superfamily. Whereas it
has been demonstrated that the deficiency of endoglin leads to minor and defective …

Endoglin/CD105 is a membrane protein involved in the TGF‐β receptor signalling pathway.
Endoglin expression has been reported to be selective for a few cell types, in particular …

Targeting of tumor vasculature is a promising strategy for cancer treatment. Among
endothelial cell markers, Endoglin, a cell membrane glycoprotein, is emerging as an …

Approximately 30 years ago, endoglin was identified as a transforming growth factor (TGF)-β
coreceptor with a crucial role in developmental biology and tumor angiogenesis. Its …

Tumor growth factor-β (TGF-β) signaling in cancer has been implicated in growth
suppression of early lesions and enhancing tumor cell invasion and metastasis. However …

Endoglin, a type-III accessory receptor for the Transforming Growth Factor (TGF)-β
superfamily pathway, is known for its crucial role during angiogenesis. Extensive work has …

Angiogenesis is crucial for tumor development and progression, and antiangiogenetic
therapy represents a promising approach for cancer treatment. Thus, the in-depth …

Endoglin (CD105) is a cell membrane glycoprotein over‐expressed on highly proliferating
endothelial cells in culture, and on endothelial cells of angiogenetic blood vessels within …